发明名称 Substituted 5-benzyl-2,4-diaminopyrimidines.
摘要 The invention relates to substituted 5-benzyl-2,4-diaminopyrimidines of general formula (A)wherein R<1 >is C2-C3 alkyl an R<2 >is heterocyclyl, phenyl or naphthyl, bonded by one of its C-atoms and R<3 >is C2-C6 alkyl, alkenyl, cycloalkyl, cycloalkylalkyl, heterocyclylalkyl, alkylsulfonyl, cycloalkylsulfonyl, cycloalkylalkylsulfamoyl, heterocyclysylfonyl, heterocyclylalkylsulfonyl or dialkylsulfamoyl; wherein alkyl, cycloalkyl and alyenyl can carry up to 6 carbon atoms alone or in compositions and can carry up to 6 ring members heterocyclically, alone, or in compositions and the groups R<2 >and R<3 >can be substituted; and to acid addition salts of compounds. The invention also relates to a method for producing the above 5-benzyl-2,4-diaminopyrimidines, to the intermediate. products that are produced, to corresponding medicaments and to the use of 5-benzyl-2,4-diaminopyrimidines as medicinal preparations. The products have antibiotic properties and are useful for combating or preventing infectious diseases.
申请公布号 ZA200203493(B) 申请公布日期 2003.08.04
申请号 ZA20020003493 申请日期 2002.05.22
申请人 BASILEA PHARMACEUTICA AG. 发明人 PHILIPPE GUERRY;MARC MULLER;PHILIPPE PFLIEGER;PETER MOHR;WERNER MUELLER
分类号 A61K31/505;A61K31/506;A61K31/5377;A61K31/538;A61P31/00;A61P31/04;A61P43/00;C07D239/48;C07D239/49;C07D401/10;C07D401/12;C07D403/10;C07D405/10;C07D405/12;C07D409/10;C07D409/12;C07D413/10;C07D417/12 主分类号 A61K31/505
代理机构 代理人
主权项
地址